🇺🇸 FDA
Patent

US 11266611

More potent and less toxic formulations of epinephrine and methods of medical use

granted A61KA61K2300/00A61K31/137

Quick answer

US patent 11266611 (More potent and less toxic formulations of epinephrine and methods of medical use) held by Eton Pharmaceuticals, Inc. expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Eton Pharmaceuticals, Inc.
Grant date
Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2300/00, A61K31/137, A61K45/06, A61K47/02